Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...
Investor's Business Daily on MSN

Littelfuse Gets Relative Strength Rating Upgrade

On Monday, Littelfuse LFUS received an upgrade to its Relative Strength (RS) Rating, from 69 to 72. Please watch the video at Investors.com - How To Buy Stocks: Do You Know Your Stock's Personality ...